• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2019.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Amid coronavirus rally, Israeli biotech taps Wall St.
    July 22, 2020
    Intage and Trax Join Forces to Drive Digital Transformation of Japan’s Reta
    July 17, 2020
    Trax and Nielsen Bring Deeper Shelf Insights to CPG Brands
    July 15, 2020
    Israeli researchers provide evidence microdosing cannabis relieves pain
    July 2, 2020
    PolyPid Initiates First Phase 3 Clinical Trial of D-PLEX100 for the Preventio
    July 1, 2020
    Israeli Researchers Tout ‘1st Clinical Evidence’ That Controlled Doses Of
    July 1, 2020
    PolyPid Ltd. Announces Closing of Initial Public Offering and Full Exercise o
    June 30, 2020
    PolyPid raises $60m at third IPO attempt
    June 28, 2020
    Mylan invests $20m more in Mapi's monthly Copaxone
    June 15, 2020
    Medison Pharma and Alpha Tau Medical Announce a Collaboration in the Oncology
    June 15, 2020